MoneyWorks4Me

Lupin - Quaterly Results

03 Feb 2022 Evaluate
Revenue reduced marginally to stand at Rs. 27319.90 millions during the quarter ended December 2021. The figure stood at Rs. 28024.70 millions during the year-ago period.Net Profit for the quarter ended December 2021 zoomed to 143.04% from Rs. 2182.50 millions to Rs. 5304.40  millions.A decline of 2437.00 millions was observed in the OP in the quarter ended December 2021 from 4296.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 27319.90 28024.70 -2.51 89162.80 85401.50 4.40 110559.30 110256.60 0.27
Other Income 372.50 222.20 67.64 1636.10 815.20 100.70 1290.90 4751.90 -72.83
PBIDT 2437.00 4296.50 -43.28 -910.20 16820.30 -105.41 21731.50 23828.00 -8.80
Interest 158.10 105.00 50.57 488.90 283.10 72.70 406.20 525.90 -22.76
PBDT 2278.90 4191.50 -45.63 -1399.10 16537.20 -108.46 21325.30 15710.00 35.74
Depreciation 1279.10 1270.80 0.65 3831.70 3778.20 1.42 5028.30 5187.50 -3.07
PBT 999.80 2920.70 -65.77 -5230.80 12759.00 -141.00 16297.00 10522.50 54.88
TAX -4304.60 738.20 -683.12 -3702.70 3336.40 -210.98 3710.80 3247.00 14.28
Deferred Tax -5455.40 -80.60 6668.49 -3725.70 -154.40 2313.02 82.30 -373.50 -122.03
PAT 5304.40 2182.50 143.04 -1528.10 9422.60 -116.22 12586.20 7275.50 72.99
Equity 908.40 907.00 0.15 908.40 907.00 0.15 907.40 906.00 0.15
PBIDTM(%) 8.92 15.33 -41.82 -1.02 19.70 -105.18 19.66 21.61 -9.05
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..